Idera Pharmaceuticals
HomeSitemapCareersContact   
 
About IderaPipelineOur ScienceOur PartnersInvestorsContact
 
  
 
   News 
 Investors
 

 

Printer Friendly Version Print Page | E-mail this page E-mail this page | RSS RSS Feeds | Download Financial Tear Sheet Financial Tear Sheet
Webcast ImageWebcast
Idera Pharmaceuticals, Inc. at Rodman & Renshaw Global Investment Conference (Live)
09/15/10 at 10:50 a.m. ET
Idera Pharmaceuticals, Inc. at Rodman & Renshaw Global Investment Conference
Wednesday, September 15, 2010 10:50 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Listen to the Webcast in Real Player Click here for webcast
Webcast ImageWebcast
Idera Pharmaceuticals, Inc. at UBS Global Life Sciences Conference (Live)
09/20/10 at 7:30 a.m. ET
Idera Pharmaceuticals, Inc. at UBS Global Life Sciences Conference
Monday, September 20, 2010 7:30 a.m. ET  
Webcast PresentationHelp Help
Listen to the Webcast in Windows Media Player Listen to the Webcast in Real Player Click here for webcast
Keyword Search
 
2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
12/11/06Merck & Co., Inc. and Idera Pharmaceuticals Sign Collaboration Agreement Incorporating Idera’s Toll-like Receptor Agonists in Merck’s Vaccine Programs
Click here to access PDF press release.... 
Printer Friendly Version
11/30/06Idera Pharmaceuticals to Present BMO Capital Markets
Click here to access PDF press release. ... 
Printer Friendly Version
11/14/06Idera Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2006
Click here to access PDF press release.... 
Printer Friendly Version
11/10/06Idera Presents Preclinical Data on Novel Class of Toll-Like Receptor Antagonists
Click here to access PDF press release.... 
Printer Friendly Version
11/01/06Idera Pharmaceuticals to Present at Rodman & Renshaw 8th Annual Healthcare Conference
Click here to access PDF press release.... 
Printer Friendly Version
10/24/06Idera to Draw Down $4 Million under Existing Equity Vehicle
Click here to access PDF press release.... 
Printer Friendly Version
10/04/06Idera Pharmaceuticals Announces Issuance of a US Patent for Method of Inducing an Immune Response through Administration of Immune Modulatory Oligonucleotides
Click here to access PDF press release.... 
Printer Friendly Version
09/13/06Idera Pharmaceuticals Announces the Issuance of US Patent Claiming Compounds that Target Toll-like Receptor 9
Click here to access PDF press release.... 
Printer Friendly Version
09/01/06Idera Pharmaceuticals to Present at Upcoming Investor Conferences
Click here to access PDF press release.... 
Printer Friendly Version
08/15/06Idera Pharmaceuticals Announces 2006 Financial Results for the Three and Six Months Ended June 30, 2006
Click here to access PDF press release.... 
Printer Friendly Version
07/25/06Idera Pharmaceuticals Announces Formation of Oncology Clinical Advisory Board
Click here to access PDF press release.... 
Printer Friendly Version
07/17/06Idera Pharmaceuticals Announces the Granting of Patents on Immune Modulatory Compounds that Target Toll-like Receptors
Click here to access PDF press release.... 
Printer Friendly Version
07/10/06Idera to Draw Down $3.5 Million under Existing Equity Vehicle
Click here to access PDF press release.... 
Printer Friendly Version
06/29/06Idera Pharmaceuticals Announces Effectiveness of Reverse Split
Click here to access PDF press release.... 
Printer Friendly Version
06/22/06Idera Pharmaceuticals to Effect a Reverse Stock Split
Click here to access PDF press release.... 
Printer Friendly Version
06/05/06Idera Presents Preclinical Data at ASCO on Agonists to Toll-like Receptor 9 in Combination with Chemotherapeutic and Targeted Therapies in Lung Cancer Models
Click here to access PDF press release.... 
Printer Friendly Version
05/15/06Idera Pharmaceuticals Broadens Toll-like Receptor Programs
Click here to access PDF press release.... 
Printer Friendly Version
04/06/06Idera Pharmaceuticals Management to Make Presentations at BIO 2006
Click here to access PDF press release.... 
Printer Friendly Version
03/27/06IDERA PHARMACEUTICALS SECURES $19.5 MILLION IN FUNDING
Click here to access PDF press release.... 
Printer Friendly Version
02/13/06IDERA PHARMACEUTICALS TO PARTICIPATE IN FOCUS SESSION AT BIO CEO & INVESTOR CONFERENCE
Click here to access PDF press release.... 
Printer Friendly Version
 
     
 
 
© 2009 Idera Pharmaceuticals Inc.
About IderaPipelineOur SciencePartnersInvestorsContactTerms of Use